Metastatic renal medullary carcinomas

Clinical trials for Metastatic renal medullary carcinomas explained in plain language.

Never miss a new study

Get alerted when new Metastatic renal medullary carcinomas trials appear

Sign up with your email to follow new studies for Metastatic renal medullary carcinomas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Immune-Drug combo aims to shrink rare kidney tumors before surgery

Disease control Not yet recruiting

Researchers are testing two drugs, toripalimab and axitinib, in adults with advanced non-clear cell kidney cancer or renal medullary carcinoma who have not received prior treatment and still have their primary kidney tumor. Everyone receives the drugs for about 12 weeks. Then a t…

Matched conditions: METASTATIC RENAL MEDULLARY CARCINOMAS

Phase 2 • Sponsor: Fudan University • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC

Metastatic renal medullary carcinomas

Get alerted when new Metastatic renal medullary carcinomas trials appear

Immune-Drug combo aims to shrink rare kidney tumors before surgery